The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling

Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune adverse events following immunization (AEFI) at the World Vaccine Congress Washington 2026.

Human Challenge Models: A New Gold Standard?

Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard for establishing efficacy and safety at the World Vaccine Congress Washington 2026.

Combining Respiratory Vaccines - Balancing Efficacy, Durability and Immunization Schedules

Dr. Bill Hausdorff explores the complex dynamics of combining respiratory vaccines, focusing on how to optimize clinical efficacy and long-term durability while streamlining complex immunization schedules at the World Vaccine Congress Washington 2026.

Prove it's safe: Is this the new vaccine policy "norm?"

Dr. Richard Hughes IV examines the shifting landscape of immunization mandates and public health legislation, questioning whether the heightened demand for safety proof is becoming the new standard for vaccine policy at the World Vaccine Congress Washington 2026.

Building a Future of Vaccine Trust Through Transparency and Innovation

Dr. Yurong Fei-Bloom explores the essential strategies for fostering public confidence in immunization by prioritizing transparency and leveraging technological advancements at the World Vaccine Congress Washington 2026.